HOME › DRUGS › DUVELISIB
ACTIVE SUBSTANCE / INN

DUVELISIB

Brand name(s): COPIKTRA, Copiktra
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
NDA211155
Leukemia, Lymphocytic, Chronic, B-Cell;Lymphoma, Follicular
ACTIVE SUBSTANCE
Duvelisib
REGULATORS
FDA · EMA
SPONSORS / MAH
Secura Bio Limited, SECURA
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
COPIKTRANDA211155SECURAPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
CopiktraSecura Bio LimitedAuthorised19/05/2021Leukemia, Lymphocytic, Chronic, B-Cell;Lymphoma, Follicular

FULL INTELLIGENCE ON DUVELISIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →